Strand AI

Multimodal foundation models to predict uncollected patient biology

HealthcareDrug Discovery and Delivery https://strandai.com ↗

Company facts

Early-stage
Founded
2026
Employees
2
Headquarters
United States

About

Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.